Literature DB >> 25940763

Upregulation of tissue inhibitor of metalloproteinase-1 contributes to restoration of the extracellular matrix in the rabbit basilar artery during cerebral vasospasm after subarachnoid hemorrhage.

Ryota Kurogi1, Yuichiro Kikkawa2, Satoshi Matsuo1, Akira Nakamizo3, Masahiro Mizoguchi1, Tomio Sasaki1.   

Abstract

Vascular remodeling caused by extracellular matrix (ECM) metabolism contributes to the development of cerebral vasospasm after subarachnoid hemorrhage (SAH). The balance between tissue inhibitor of metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs) plays an important role in ECM remodeling. We investigated the mechanism of vascular remodeling following cerebral vasospasm in a rabbit double hemorrhage model. Rabbit basilar arteries were harvested on days 3, 5, and 7 after initial hemorrhage. TIMP-1, TIMP-2, MMP-2, and MMP-9 mRNA and protein expression were investigated with microarray analysis, quantitative real-time PCR, immunoblot analysis, and enzyme-linked immunosorbent assay (ELISA). The expression and localization of TIMP-1, TIMP-2, MMP-2, MMP-9, elastin, fibronectin, laminin, and collagens I, III, and IV were investigated with immuohistochemical staining. After SAH, TIMP-1 mRNA and protein expression were significantly increased on day 3 and then decreased to the control level on days 5 and 7. MMP-9 protein expression was significantly increased on day 7. TIMP-2 and MMP-2 mRNA and protein expression were significantly increased on day 7. Elastin, fibronectin, laminin, and collagens I, III, and IV protein expression was decreased on day 3 and then restored to control levels on day 7. Upregulation of TIMP-1 during the early phase of cerebral vasospasm may contribute to the recovery of the ECM during the late phase of cerebral vasospasm, resulting in a protective role of TIMP-1 from cerebral vasospasm. Moreover, the increase in arterial compliance by the decrease in ECM during the early phase of cerebral vasospasm may facilitate vasoconstriction of the cerebral artery.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral vasospasm; Extracellular matrix; Matrix metalloproteinase; Subarachnoid hemorrhage; Tissue inhibitor of metalloproteinase; Vascular remodeling

Mesh:

Substances:

Year:  2015        PMID: 25940763     DOI: 10.1016/j.brainres.2015.04.049

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Expression of MMP-9 and IL-6 in patients with subarachnoid hemorrhage and the clinical significance.

Authors:  Luchen Wang; Ziyun Gao
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

Review 2.  Hydrocephalus after Subarachnoid Hemorrhage: Pathophysiology, Diagnosis, and Treatment.

Authors:  Sheng Chen; Jinqi Luo; Cesar Reis; Anatol Manaenko; Jianmin Zhang
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

3.  Gene expression profiling of brain endothelial cells after experimental subarachnoid haemorrhage.

Authors:  Michael K Tso; Paul Turgeon; Bert Bosche; Charles K Lee; Tian Nie; Josephine D'Abbondanza; Jinglu Ai; Philip A Marsden; R Loch Macdonald
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

4.  Circular RNA RBM33 contributes to extracellular matrix degradation via miR-4268/EPHB2 axis in abdominal aortic aneurysm.

Authors:  Shizhi Wang; Qingwen Yuan; Wenpeng Zhao; Weimin Zhou
Journal:  PeerJ       Date:  2021-11-16       Impact factor: 2.984

5.  Genome-Wide Association Study of the Relationship Between Matrix Metalloproteinases and Intracranial Aneurysms.

Authors:  Bong Jun Kim; Eun Pyo Hong; Dong Hyuk Youn; Jin Pyeong Jeon
Journal:  J Clin Neurol       Date:  2022-02-14       Impact factor: 3.077

Review 6.  Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH).

Authors:  Shafqat Rasul Chaudhry; Ahmad Hafez; Behnam Rezai Jahromi; Thomas Mehari Kinfe; Alf Lamprecht; Mika Niemelä; Sajjad Muhammad
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.